Delivery Order SPE2DE21D7020-SPE2D626F40RA
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,690.48 by the Defense Health Agency's Medical Supply Chain division on November 12, 2025, with an ultimate completion date of November 19, 2025. This fixed-price delivery order with economic price adjustment provisions was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $16,009.60 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 26, 2025, and represents performance at the company's Marlborough, MA facility. The award was issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,053.33 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 22, 2025, and will be performed at the company's Marlborough, Massachusetts facility. The delivery order is issued without a small business set-aside, allowing Boston...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,748.00 by the Defense Health Agency's Medical Supply Chain division on January 27, 2026, with an ultimate completion date of February 4, 2026. This fixed-price contract with economic price adjustment was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order is issued against a larger indefinite delivery vehicle—a...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $26,078.40 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on November 17, 2025, with an ultimate completion date of November 20, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,085.40 under a fixed-price contract with economic price adjustment provisions by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on November 6, 2025, with an ultimate completion date of November 14, 2025, represents a continuation of Boston Scientific's established role as a critical supplier of specialized radiation oncology equipment and...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,158.72 by the Defense Health Agency's Medical Supply Chain division on January 16, 2026, with an ultimate completion date of January 26, 2026. This fixed-price contract with economic price adjustment pricing was issued without a small business set-aside, allowing unrestricted competition. The delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $29,701.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by October 23, 2025, and represents work to be performed at the contractor's facility in Marlborough, MA. The award was issued without small business set-aside provisions, allowing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,094.40 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 17, 2025. This fixed-price contract with economic price adjustment was awarded on December 10, 2025, and is issued without a small business set-aside. The delivery order is placed against Boston Scientific's single-award Blanket Purchase Agreement with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,081.05 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment was issued on November 3, 2025, with an ultimate completion date of November 10, 2025. The delivery order was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The place of performance is located...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F40RADelivery Order
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $37,089.26 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment provisions carries an ultimate completion date of February 10, 2026, and was awarded on February 3, 2026. The award is issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued under Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health Agency, valued at $750,000 with a ceiling and completion date of March 30, 2030, which was awarded on March 31, 2025. The BPA designates Boston Scientific as the sole supplier for radiation treatment devices. Under this delivery order and related indefinite delivery vehicle, Boston Scientific fulfills resupply requirements for specialized radiation oncology equipment and related technologies across military healthcare facilities and Veterans Affairs medical centers. The company's portfolio includes yttrium-90 glass microspheres, radiopharmaceuticals, and advanced radiation treatment modalities that support critical cancer care capabilities across the defense and veterans healthcare enterprises. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.1k | 2/2/26 |